CoChat

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?

Open access
Duncan Jr, Wallace C, Slonena, Elizabeth E, Hejazi, Nadia S, Brutsche, Nancy, Park, Lawrence T, Henter, Ioline D, Ballard, Elizabeth D, Zarate Jr, Carlos A · 2018 · Neuropsychiatric Disease and Treatment

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

PURPOSE: This study examined the links between 24-hour activity patterns (specifically, amplitude and timing of wrist activity) and the persisting qualities of clinical antidepressant response to the glutamatergic modulator ketamine. METHODS: Twenty-four-hour activity patterns were compared across 5 days of 24-hour activity rhythms in patients with major depressive disorder who displayed either a brief antidepressant response (24-48 hours), a continued antidepressant response (>72 hours), or no antidepressant response to ketamine. These postinfusion-response profiles were then used retrospectively to examine cohort-specific fitted parameters at baseline, postinfusion day 1 (D1), and postinfusion D3. RESULTS: Relative to the nonresponders, the cohort experiencing a brief antidepressant response had blunted 24-hour amplitude that extended from baseline through D3 and postketamine phase advance of activity on D1 that reverted to baseline on D3. Relative to the nonresponders, the cohort experiencing a continued antidepressant response to ketamine had phase-advanced activity at both baseline and D1, as well as increased amplitude on D1 and D3. CONCLUSION: Taken together, the results suggest that the time course of antidepressant response to ketamine is influenced by underlying biological differences in motor activity timekeeping. These differences may provide clues that link durable mood response with the molecular machinery of the circadian system, thus leading to more effective interventions. In addition, biomarkers of preinfusion motor activity (eg, amplitude, timing) may be useful for recommending future individualized treatment interventions, to the extent that they help identify patients who may relapse quickly after treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ndt.s172089

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Baseline and ketamine treatment 24-hour motor activity markers of rapid mood response. Notes: Mean ± SEM estimated amplitude (left) and timing (phase; right) parameters for a 24-hour sinusoidal curve fit to wrist activity shown for three ketamine-treated patient cohorts: brief responders (RB), continued responders (RC), and nonresponders (NR). Parameter values shown for 3 days: baseline (BL), day 1 (D1) postketamine, and day 3 (D3) postketamine. Amplitude is expressed in mean activity counts/minute/hour, and timing is the clock time of estimated peak activity. Bonferroni-corrected α-criterion was set to P<0.0167. Letters above bars indicate the results comparing the amplitude and phase parameters of the NR cohort with the RC and RB cohorts. Numerals above bars indicate the results comparing the amplitude and timing parameters between the RC and RB cohorts. Group contrasts: a, b, P<0.05 (NS) and 0.005, respectively; 1, 2, P<0.05 (NS) and 0.005, respectively, vs RC. Abbreviation: NS, not significant.
Figure 1 Baseline and ketamine treatment 24-hour motor activity markers of rapid mood response. Notes: Mean ± SEM estimated amplitude (left) and timing (phase; right) parameters for a 24-hour sinusoidal curve fit to wrist activity shown for three ketamine-treated patient cohorts: brief responders (RB), continued responders (RC), and nonresponders (NR). Parameter values shown for 3 days: baseline (BL), day 1 (D1) postketamine, and day 3 (D3) postketamine. Amplitude is expressed in mean activity counts/minute/hour, and timing is the clock time of estimated peak activity. Bonferroni-corrected α-criterion was set to P<0.0167. Letters above bars indicate the results comparing the amplitude and phase parameters of the NR cohort with the RC and RB cohorts. Numerals above bars indicate the results comparing the amplitude and timing parameters between the RC and RB cohorts. Group contrasts: a, b, P<0.05 (NS) and 0.005, respectively; 1, 2, P<0.05 (NS) and 0.005, respectively, vs RC. Abbreviation: NS, not significant.CC BY-NC · PubMed Central
Figure 2 Baseline (BL), day 1 (D1), and day 3 (D3) Montgomery–Åsberg Depression Rating Scale (MADRS) score. Notes: Baseline (BL), day 1 (D1), and day 3 (D3) Montgomery-Asberg Depression Rating Scale (MADRS) scores in three patient cohorts: brief responders (RB), continued responders (RC), and nonresponders (NR). No differences among group scores were observed at BL. On D1, scores for the NR cohort were higher than for both the RB and RC cohorts, which did not differ from each other. On D3, scores for the NR and RB cohorts were both higher than for the RC cohort.
Figure 2 Baseline (BL), day 1 (D1), and day 3 (D3) Montgomery–Åsberg Depression Rating Scale (MADRS) score. Notes: Baseline (BL), day 1 (D1), and day 3 (D3) Montgomery-Asberg Depression Rating Scale (MADRS) scores in three patient cohorts: brief responders (RB), continued responders (RC), and nonresponders (NR). No differences among group scores were observed at BL. On D1, scores for the NR cohort were higher than for both the RB and RC cohorts, which did not differ from each other. On D3, scores for the NR and RB cohorts were both higher than for the RC cohort.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

Metadata

Authors
Duncan Jr, W. C., Slonena, E. E., Hejazi, N. S., Brutsche, N., Park, L. T., Henter, I. D., Ballard, E. D., & Zarate Jr, C. A.
Affiliations
National Institutes of Health (US)
Venue
Neuropsychiatric Disease and Treatment
Published
2018-10
Volume
Volume 14
Pages
2739-2748
ISSN
  • 1176-6328 (ISSN-L)
  • 1178-2021
OpenAlex
W2898047836
Cited by
17
References
62
Citations by year
2026: 3 · 2025: 1 · 2023: 2 · 2021: 6 · 2020: 4 · 2019: 1
FWCI
1.77
Type
journal article
Language
en
Open access
Locations
  • Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
  • National Alliance for Research on Schizophrenia and Depression
  • National Institute of Mental Health and Neurosciences
  • National Institutes of Health (NCT00088699)
  • National Institute of Mental Health (NCT00088699, ZIAMH002927)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
ketamine, major depressive disorder, circadian rhythm, wrist actigraphy, antidepressant response, phase advance, circadian amplitude, circadian system, biomarkers, treatment response prediction, relapse

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.